Xtant Medical Holdings, Inc. (XTNT)

Xtant Medical Holdings Stock Forecast

Stock Price Forecast

The 1 analyst with a 12-month price forecast for Xtant Medical Holdings stock has a target of 1.00, which predicts a 108.33% increase from the current stock price of 0.48.

Price Target: $1.00 (+108.33%)

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$1.00	$1.00	$1.00	$1.00
Change	+108.33%	+108.33%	+108.33%	+108.33%

Analyst Ratings

According to 1 stock analyst, the rating for Xtant Medical Holdings is "Strong Buy". This means that the analyst believes this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Nov '25	Dec '25	Jan '26	Feb '26	Mar '26	Apr '26
Strong Buy	1	1	1	1	1	1
Buy	0	0	0	0	0	0
Hold	0	0	0	0	0	0
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	1	1	1	1	1	1

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Ryan Zimmerman BTIG	BTIG	Strong Buy Maintains $1.5 → $1	Strong Buy	Maintains	$1.5 → $1	+108.33%	Mar 31, 2026
Ryan Zimmerman BTIG	BTIG	Strong Buy Maintains $2 → $1.5	Strong Buy	Maintains	$2 → $1.5	+212.50%	Nov 11, 2025
Ryan Zimmerman BTIG	BTIG	Strong Buy Maintains $2 → $3	Strong Buy	Maintains	$2 → $3	+525.00%	May 16, 2024
Ryan Zimmerman BTIG	BTIG	Strong Buy Initiates $2	Strong Buy	Initiates	$2	+316.67%	Dec 5, 2023
Chase Knickerbocker Craig-Hallum	Craig-Hallum	Strong Buy Maintains $1 → $1.2	Strong Buy	Maintains	$1 → $1.2	+150.00%	Jul 11, 2023

More Analyst Ratings

Financial Forecast

Revenue This Year

98.12M

Decreased by -26.73%

from 133.93M

Revenue Next Year

107.25M

Increased by 9.30%

from 98.12M

EPS This Year

-0.03

from 0.03

EPS Next Year

-0.01

from -0.03

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	55.26M	57.97M	91.30M	117.27M	133.93M	98.12M	107.25M
Revenue Growth	3.61%	4.90%	57.50%	28.44%	14.21%	-26.73%	9.30%
EPS	-0.06	-0.09	0.01	-0.12	0.03	-0.03	-0.01
EPS Growth	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	4	4

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2026	2027	2028
High	101.9M	111.6M
Avg	98.1M	107.3M
Low	93.5M	101.9M

Revenue Growth

Revenue Growth	2026	2027	2028
High	-24.0%	13.8%
Avg	-26.7%	9.3%
Low	-30.2%	3.9%

EPS Forecast

EPS	2026	2027	2028
High	-0.01	0.01
Avg	-0.03	-0.01
Low	-0.05	-0.02

EPS Growth

EPS Growth	2026	2027	2028
High	-	-
Avg	-	-
Low	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.